Stocktoria

HAEMONETICS CORP HAE

NYSE · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1979-10-17 · LEI

HAEMONETICS CORP statistics & valuation

Market cap$3.5B
P / E36.1×
P / S2.6×
P / B4.4×
P / FCF13.5×
Net margin7.3%
Return on equity12.2%
FCF margin19.5%
Net debt$994.4M
Net debt / EBITDA3.7×
Enterprise value USD$4.5B
EV / EBITDA16.8×
Earnings yield EBIT/EV3.5%
Return on capital7.4%
Graham number -69.5%$27.85

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($27.85); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
-3.00% 5.00% 5.70% 7.70% 9.10% 4.40% 9.90% 9.00% 12.30% 7.30% 2017201820192020202120222023202420252026
Gross margin (%)
42.70% 45.60% 43.20% 49.00% 45.70% 50.90% 52.60% 52.80% 55.00% 59.00% 2017201820192020202120222023202420252026
Operating margin (%)
-2.20% 6.20% 8.60% 10.50% 10.30% 8.10% 13.40% 12.60% 16.30% 11.70% 2017201820192020202120222023202420252026
Return on equity (%)
-3.60% 6.10% 8.20% 13.00% 10.90% 5.80% 14.10% 12.20% 20.40% 12.20% 2017201820192020202120222023202420252026
Shares outstanding
52.3M 53.5M 52.9M 51.8M 51.3M 51.4M 51.4M 51.4M 50.7M 47.4M 2017201820192020202120222023202420252026
Net debt ($)
$176.2M -$120.7M $153.1M $168.2M $498.3M $299.9M $469.6M $618.8M $918.0M $994.4M 2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
-2.10% 3.70% 4.30% 6.00% 4.40% 2.30% 6.00% 5.40% 6.80% 4.10% 2017201820192020202120222023202420252026
Free cash flow margin (%)
9.40% 16.10% 4.20% 11.10% 8.20% 7.60% 7.00% 11.00% 10.50% 19.50% 2017201820192020202120222023202420252026
Debt / equity (×)
0.43× 0.08× 0.48× 0.52× 0.94× 0.75× 0.92× 0.83× 1.49× 1.56× 2017201820192020202120222023202420252026
EPS ($)
-$0.51 $0.85 $1.04 $1.48 $1.55 $0.84 $2.24 $2.29 $3.31 $2.05 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

HAEMONETICS CORP trades at about 44.6× earnings — below its 10-year norm (10-year range 19×–126.7×, median 60.3×).

19× 126.7×

Shaded band = 10-year range (19×–126.7×); dot = today's 44.6×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin59.0%55.0%52.8%52.6%50.9%45.7%49.0%43.2%45.6%42.7%
Operating margin11.7%16.3%12.6%13.4%8.1%10.3%10.5%8.6%6.2%-2.2%
Net margin7.3%12.3%9.0%9.9%4.4%9.1%7.7%5.7%5.0%-3.0%
FCF margin19.5%10.5%11.0%7.0%7.6%8.2%11.1%4.2%16.1%9.4%
Return on assets4.1%6.8%5.4%6.0%2.3%4.4%6.0%4.3%3.7%-2.1%
Return on equity12.2%20.4%12.2%14.1%5.8%10.9%13.0%8.2%6.1%-3.6%
Debt / equity1.56×1.49×0.83×0.92×0.75×0.94×0.52×0.48×0.08×0.43×
Current ratio2.951.622.563.061.712.742.202.441.352.42

Computed from company filings · US · as of 2026-03-28. Facts plus Stocktoria's own computed scores — not investment advice.